SEARCH

SEARCH BY CITATION

References

  • 1
    Kofidis T, Pethig K, Ruther G et al. Traveling after heart transplantation. Clin Transplant 2002; 16: 280284.DOI: 10.1034/j.1399-0012.2002.01144.x
  • 2
    Boggild AK, Sano M, Humar A, Salit I, Gilman M, Kain KC. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med 2004; 11: 3743.
  • 3
    Ryan ET, Kain KC. Health advice and immunizations for travelers. N Engl J Med 2000; 342: 17161725.DOI: 10.1056/NEJM200006083422306
  • 4
    Conlon CP. The Immunocompromised Traveler. In: StefferR, ed. Textbook of travel medicine and health: B.C. Decker, 2001: 464469.
  • 5
    Mileno M. Preparation of immunocompromised travelers. In: KeystoneJS, KozarskyDO, NothdurftHD, ConnorBA, eds. Travel medicine. Edinburgh : Mosby, 2004: 249255.
  • 6
    Centers for Disease Control, Department of Health and Human Services. Health Information for International Travel 2003–2004, Atlanta , Georgia , 2003.
  • 7
    Ljungman P. Vaccination of transplant recipients. In: BowdenRA, LjungmanP, PayaCV, eds. Transplant infections. Philadelphia : Lippincott Williams & Wilkins, 2003: 611624.
  • 8
    Avery RK, Ljungman P. Prophylactic measures in the solid-organ recipient before transplantation. Clin Infect Dis 2001; 33(Suppl 1): S15S21.
  • 9
    Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003; 16: 357364.
  • 10
    Panackal AA, Hajjeh RA, Cetron MS, Warnock DW. Fungal infections among returning travelers. Clin Infect Dis 2002; 35: 10881095.
  • 11
    Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001; 345: 107114.
  • 12
    Blumberg EA, Brozena SC, Stutman P, Wood D, Phan HM, Musher DM. Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Infect Dis 2001; 32: 307310.
  • 13
    Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998; 17: 10751080.
  • 14
    Kobashigawa JA, Warner-Stevenson L, Johnson BL et al. Influenza vaccine does not cause rejection after cardiac transplantation. Transplant Proc 1993; 25: 27382739.
  • 15
    Rubin RH. Influenza and the transplant recipient. Transpl Infect Dis 2002; 4: 175176.
  • 16
    Bienzle U, Gunther M, Neuhaus R et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003; 38: 811819.
  • 17
    Molrine DC, Hibberd PL. Vaccines for transplant recipients. Infect Dis Clin North Am 2001; 15: 273305 (Section XII).
  • 18
    Rand EB, McCarthy CA, Whitington PF. Measles vaccination after orthotopic liver transplantation. J Pediatr 1993; 123: 8789.
  • 19
    Hayney MS, Welter DL, Reynolds AM, Francois M, Love RB. High-dose hepatitis B vaccine in patients waiting for lung transplantation. Pharmacotherapy 2003; 23: 555560.
  • 20
    Choy BY, Peiris JS, Chan TM, Lo SK, Lui SL, Lai KN. Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients. Am J Transplant 2002; 2: 965969.
  • 21
    Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation 2001; 72: 272276.
  • 22
    Dumot JA, Barnes DS, Younossi Z et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol 1999; 94: 16011604.
    Direct Link:
  • 23
    Stark K, Gunther M, Neuhaus R et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 1999; 180: 20142017.
  • 24
    Gunther M, Stark K, Neuhaus R, Reinke P, Schroder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 2001; 71: 477479.
  • 25
    Kroon FP, Van Dissel JT, Ravensbergen E, Nibbering PH, Van Furth R. Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-VI). Vaccine 1999; 17: 29412945.
  • 26
    Parkkali T, Kayhty H, Lehtonen H et al. Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients. Bone Marrow Transplant 2001; 27: 7984.
  • 27
    Cetron MS, Marfin AA, Julian KG et al. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 2002; 51: 111 (quiz CE1–4).
  • 28
    Fishman JA. Smallpox and live-virus vaccination in transplant recipients. Am J Transplant 2003; 3: 786793.
  • 29
    Gowda R, Cartwright K, Bremner JA, Green ST. Yellow fever vaccine: A successful vaccination of an immunocompromised patient. Eur J Haematol 2004; 72: 299301.
  • 30
    Receveur MC, Thiebaut R, Vedy S, Malvy D, Mercie P, Bras ML. Yellow fever vaccination of human immunodeficiency virus-infected patients: Report of 2 cases. Clin Infect Dis 2000; 31: E7E8.
  • 31
    Tattevin P, Depatureaux AG, Chapplain JM et al. Yellow fever vaccine is safe and effective in HIV-infected patients. AIDS 2004; 18: 825827.
  • 32
    Kengsakul K, Sathirapongsasuti K, Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 2002; 85: 131134.
  • 33
    Gibbons RV, Rupprecht CE. Postexposure rabies prophylaxis in immunosuppressed patients. JAMA 2001; 285: 15741575.
  • 34
    Tantawichien T, Jaijaroensup W, Khawplod P, Sitprija V. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4 + T lymphocyte counts. Clin Infect Dis 2001; 33: E122E124.
  • 35
    Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1993; 42: 115.
  • 36
    Rojanasuphot S, Shaffer N, Chotpitayasunondh T et al. Response to JE vaccine among HIV-infected children, Bangkok, Thailand. Southeast Asian J Trop Med Public Health 1998; 29: 443450.
  • 37
    Recommended Adult Immunization Schedule—United States, 2003–2004. Morb Mortal Wkly Rep 2003; 52: 965969.